Projects funded by the NCN

Novel multi-target ligands of aminergic GPCRs as pharmacological tools to study the pathomechanism of schzophrenia

Call: OPUS 14 , Panel: NZ7

Principal investigator: dr hab. Agnieszka Kaczor

Uniwersytet Medyczny w Lublinie, Wydział Farmaceutyczny

The sensitization of pancreatic cancer cells to pulsed electric field and electrochemotherapy - from molecular modeling ...

Call: PRELUDIUM 14 , Panel: NZ3

Principal investigator: dr Olga Michel

Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Lekarski

Dialysate bicarbonate profilling and phosphate removal during hemodialysis

Call: PRELUDIUM 13 , Panel: NZ5

Principal investigator: Michał Michalec

Uniwersytet Warszawski, Wydział Chemii

Methods for determining new ultrasonic parameters of tumor tissue. Their physical interpretation and evaluation of the u...

Call: OPUS 12 , Panel: ST8

Principal investigator: prof. Jerzy Litniewski

Instytut Podstawowych Problemów Techniki Polskiej Akademii Nauk

Editing of HNF1A gene in human induced pluripotent stem cells with CRISPR/Cas9 for disease modeling of endothelial (dys)...

Call: OPUS 12 , Panel: NZ1

Principal investigator: dr Neli Kachamakova-Trojanowska

Uniwersytet Jagielloński, Małopolskie Centrum Biotechnologii Uniwersytetu Jagiellońskiego

Multifunctional inhibitors of beta-secretase with anti-aggregating properties of neurotoxic peptides - beta-amyloid and ...

Call: OPUS 11 , Panel: NZ7

Principal investigator: prof. Barbara Malawska

Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

Uncovering the mechanisms, transcriptome and metabolome signatures of ketone-prone diabetes using induced pluripotent st...

Call: POLONEZ 1 , Panel: NZ3

Principal investigator: dr hab. Małgorzata Borowiak

Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Biologii

Design, synthesis and analysis of electrospun materials based on biodegradable polymers as potential drug delivery syste...

Call: PRELUDIUM 9 , Panel: ST8

Principal investigator: Marek Rychter

Uniwersytet im. Adama Mickiewicza w Poznaniu, Centrum Nanobiomedyczne